Agenda Topics- Cancer Biology and Stem Cell Signalling
- Cardiac iPSCs for Drug Discovery
- Developments from the EBiSC
- Disease Modelling and Phenotypic Drug Screening
- Partnering; Academia, Hospitals and Pharma
Sponsorship and Exhibition OpportunitiesExhibition Team, exhibitors@selectbio.com +44 (0) 1206 501654
|
Distinguished FacultyLauren Drowley, Associate Principal Scientist, AstraZeneca David Hay, Chair of Tissue Engineering, MRC Centre for Regenerative Medicine, University of Edinburgh Timothy Allsopp, Co-ordinator IMI EBiSC Project, Pfizer Zameel Cader, Director and Principal Scientist, IMI StemBANCC, University of Oxford Davide Danovi, Director, Cell Phenotyping Platform, Kings College London Joseph Wu, Director/Professor, Stanford University School of Medicine Francesco Saverio Tedesco, Principal Research Associate, University College London Faye Drawnel, Scientist, Pharma Research and Early Development, Roche Chris Ward, Senior Lecturer, University of Manchester Gary Gintant, Senior Research Fellow, Abbvie Lorenz Mayr, Vice President, AstraZeneca Ltd
|